SCHEMBL9302623

SCHEMBL9302623

CCOP(=O)(O)C(N1CCC(C)(O)CC1)P(=O)(O)O

nearest known ligand 0.37

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
FDPS P14324 3/20 0.37
TSHR P16473 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9302643 0.89 FDPS (0.38) FDPSTSHR
SCHEMBL9300897 0.87 FDPS (0.36) FDPSTSHR
SCHEMBL6670360 0.85 FDPS (0.45) FDPSTSHR
SCHEMBL5075884 0.85 FDPS (0.45) FDPSTSHR
SCHEMBL9302299 0.85 OPRM1 (0.36) FDPS
SCHEMBL9302275 0.85 FDPS (0.37) FDPSTSHRSMN1; SMN2
SCHEMBL9300995 0.84 OPRM1 (0.38) FDPS
SCHEMBL9301452 0.83 FDPS (0.33) FDPS
SCHEMBL9303011 0.82 FDPS (0.54) FDPS
SCHEMBL9301941 0.81 KDM4E (0.38) FDPSTSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5350743-A Treatment of osteoporosis KAKEN PHARMACEUTICAL CO., LTD. (JP) 1994-09-27 US disclosed
EP-0498424-A1 Bisphosphonic acid derivatives and bone resorption inhibitors containing them Kaken Pharmaceutical Co., Ltd. (JP) 1992-08-12 EP disclosed